Last reviewed · How we verify
TG02 capsules oral administration, BIW in every 28d — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
TG02 capsules oral administration, BIW in every 28d (TG02 capsules oral administration, BIW in every 28d) — Lee's Pharmaceutical Limited.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| TG02 capsules oral administration, BIW in every 28d TARGET | TG02 capsules oral administration, BIW in every 28d | Lee's Pharmaceutical Limited | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- TG02 capsules oral administration, BIW in every 28d CI watch — RSS
- TG02 capsules oral administration, BIW in every 28d CI watch — Atom
- TG02 capsules oral administration, BIW in every 28d CI watch — JSON
- TG02 capsules oral administration, BIW in every 28d alone — RSS
Cite this brief
Drug Landscape (2026). TG02 capsules oral administration, BIW in every 28d — Competitive Intelligence Brief. https://druglandscape.com/ci/tg02-capsules-oral-administration-biw-in-every-28d. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab